Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Neurotoxicity evoked by organophosphates and available countermeasures

L. Pulkrabkova, B. Svobodova, J. Konecny, T. Kobrlova, L. Muckova, J. Janousek, J. Pejchal, J. Korabecny, O. Soukup

. 2023 ; 97 (1) : 39-72. [pub] 20221106

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc23004791

Organophosphorus compounds (OP) are a constant problem, both in the military and in the civilian field, not only in the form of acute poisoning but also for their long-lasting consequences. No antidote has been found that satisfactorily protects against the toxic effects of organophosphates. Likewise, there is no universal cure to avert damage after poisoning. The key mechanism of organophosphate toxicity is the inhibition of acetylcholinesterase. The overstimulation of nicotinic or muscarinic receptors by accumulated acetylcholine on a synaptic cleft leads to activation of the glutamatergic system and the development of seizures. Further consequences include generation of reactive oxygen species (ROS), neuroinflammation, and the formation of various other neuropathologists. In this review, we present neuroprotection strategies which can slow down the secondary nerve cell damage and alleviate neurological and neuropsychiatric disturbance. In our opinion, there is no unequivocal approach to ensure neuroprotection, however, sooner the neurotoxicity pathway is targeted, the better the results which can be expected. It seems crucial to target the key propagation pathways, i.e., to block cholinergic and, foremostly, glutamatergic cascades. Currently, the privileged approach oriented to stimulating GABAAR by benzodiazepines is of limited efficacy, so that antagonizing the hyperactivity of the glutamatergic system could provide an even more efficacious approach for terminating OP-induced seizures and protecting the brain from permanent damage. Encouraging results have been reported for tezampanel, an antagonist of GluK1 kainate and AMPA receptors, especially in combination with caramiphen, an anticholinergic and anti-glutamatergic agent. On the other hand, targeting ROS by antioxidants cannot or already developed neuroinflammation does not seem to be very productive as other processes are also involved.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23004791
003      
CZ-PrNML
005      
20230425171723.0
007      
ta
008      
230418s2023 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00204-022-03397-w $2 doi
035    __
$a (PubMed)36335468
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Pulkrabkova, Lenka $u Faculty of Military Health Sciences, University of Defence, Trebesska 1575, Hradec Kralove, Czech Republic $u Biomedical Research Center, University Hospital Hradec Kralove, Sokolska 581, Hradec Kralove, Czech Republic
245    10
$a Neurotoxicity evoked by organophosphates and available countermeasures / $c L. Pulkrabkova, B. Svobodova, J. Konecny, T. Kobrlova, L. Muckova, J. Janousek, J. Pejchal, J. Korabecny, O. Soukup
520    9_
$a Organophosphorus compounds (OP) are a constant problem, both in the military and in the civilian field, not only in the form of acute poisoning but also for their long-lasting consequences. No antidote has been found that satisfactorily protects against the toxic effects of organophosphates. Likewise, there is no universal cure to avert damage after poisoning. The key mechanism of organophosphate toxicity is the inhibition of acetylcholinesterase. The overstimulation of nicotinic or muscarinic receptors by accumulated acetylcholine on a synaptic cleft leads to activation of the glutamatergic system and the development of seizures. Further consequences include generation of reactive oxygen species (ROS), neuroinflammation, and the formation of various other neuropathologists. In this review, we present neuroprotection strategies which can slow down the secondary nerve cell damage and alleviate neurological and neuropsychiatric disturbance. In our opinion, there is no unequivocal approach to ensure neuroprotection, however, sooner the neurotoxicity pathway is targeted, the better the results which can be expected. It seems crucial to target the key propagation pathways, i.e., to block cholinergic and, foremostly, glutamatergic cascades. Currently, the privileged approach oriented to stimulating GABAAR by benzodiazepines is of limited efficacy, so that antagonizing the hyperactivity of the glutamatergic system could provide an even more efficacious approach for terminating OP-induced seizures and protecting the brain from permanent damage. Encouraging results have been reported for tezampanel, an antagonist of GluK1 kainate and AMPA receptors, especially in combination with caramiphen, an anticholinergic and anti-glutamatergic agent. On the other hand, targeting ROS by antioxidants cannot or already developed neuroinflammation does not seem to be very productive as other processes are also involved.
650    _2
$a lidé $7 D006801
650    _2
$a acetylcholinesterasa $x metabolismus $7 D000110
650    _2
$a reaktivní formy kyslíku $7 D017382
650    _2
$a organofosfáty $7 D010755
650    _2
$a neurozánětlivé nemoci $7 D000090862
650    12
$a neurotoxické syndromy $x etiologie $x prevence a kontrola $7 D020258
650    12
$a otrava organofosfáty $x farmakoterapie $x prevence a kontrola $7 D062025
650    _2
$a záchvaty $7 D012640
650    _2
$a cholinesterasové inhibitory $x toxicita $7 D002800
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Svobodova, Barbora $u Faculty of Military Health Sciences, University of Defence, Trebesska 1575, Hradec Kralove, Czech Republic $u Biomedical Research Center, University Hospital Hradec Kralove, Sokolska 581, Hradec Kralove, Czech Republic
700    1_
$a Konecny, Jan $u Faculty of Military Health Sciences, University of Defence, Trebesska 1575, Hradec Kralove, Czech Republic $u Biomedical Research Center, University Hospital Hradec Kralove, Sokolska 581, Hradec Kralove, Czech Republic
700    1_
$a Kobrlova, Tereza $u Biomedical Research Center, University Hospital Hradec Kralove, Sokolska 581, Hradec Kralove, Czech Republic
700    1_
$a Muckova, Lubica $u Faculty of Military Health Sciences, University of Defence, Trebesska 1575, Hradec Kralove, Czech Republic $u Biomedical Research Center, University Hospital Hradec Kralove, Sokolska 581, Hradec Kralove, Czech Republic
700    1_
$a Janousek, Jiri $u Biomedical Research Center, University Hospital Hradec Kralove, Sokolska 581, Hradec Kralove, Czech Republic
700    1_
$a Pejchal, Jaroslav $u Faculty of Military Health Sciences, University of Defence, Trebesska 1575, Hradec Kralove, Czech Republic
700    1_
$a Korabecny, Jan $u Faculty of Military Health Sciences, University of Defence, Trebesska 1575, Hradec Kralove, Czech Republic. jan.korabecny@fnhk.cz $u Biomedical Research Center, University Hospital Hradec Kralove, Sokolska 581, Hradec Kralove, Czech Republic. jan.korabecny@fnhk.cz $1 https://orcid.org/0000000169777596 $7 xx0119837
700    1_
$a Soukup, Ondrej $u Faculty of Military Health Sciences, University of Defence, Trebesska 1575, Hradec Kralove, Czech Republic. ondrej.soukup@fnhk.cz $u Biomedical Research Center, University Hospital Hradec Kralove, Sokolska 581, Hradec Kralove, Czech Republic. ondrej.soukup@fnhk.cz $1 https://orcid.org/0000000163768701
773    0_
$w MED00009265 $t Archives of toxicology $x 1432-0738 $g Roč. 97, č. 1 (2023), s. 39-72
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36335468 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230418 $b ABA008
991    __
$a 20230425171720 $b ABA008
999    __
$a ok $b bmc $g 1925088 $s 1191000
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 97 $c 1 $d 39-72 $e 20221106 $i 1432-0738 $m Archives of toxicology $n Arch Toxicol $x MED00009265
LZP    __
$a Pubmed-20230418

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...